-
Intellia Therapeutics, Inc. is an
American clinical-stage
biotechnology company focused on
developing novel,
potentially curative therapeutics leveraging...
-
EVOPLAY (2050)
Infopulse (1940)
DataArt (1900) ZONE3000 (1640)
ELEKS (1514)
Intellias (1510)
Genesis (1450)
AUTODOC (1019) EVO (1179)
Sigma Software (1083)...
-
INAVI Increment P
Corporation Archived 2020-03-10 at the
Wayback Machine Intellias Joynext Kuandeng Mapmaster (Toyota
Mapmaster Inc.)
Mappers Co. Ltd. Mitsubishi...
- 2019, the five
directors were John Leonard,
chief executive officer of
Intellia Therapeutics;
Jeffrey Smith, Starboard's own
chief executive officer; Janet...
- of
Intellia Therapeutics". www.businesswire.com.
November 18, 2014.
Archived from the
original on May 16, 2021.
Retrieved May 16, 2021. "
Intellia Therapeutics...
-
Indian Drugs and
Pharmaceuticals (1961– )
Intarcia (1995– )
Intas (1984– )
Intellia Therapeutics (2014– )
Ionis (1989– ) Ipca (1949– )
Ipsen (1929– ) ITH (2008–...
-
develop therapies for rare
diseases using CRISPR.
CRISPR Therapeutics Intellia Therapeutics Editas Medicine "Beam
Therapeutics Inc. FORM 10-K". U.S. Securities...
- /bio-wonder-ind-p-0002kc https://somanirealtors.com/project/rudramani "
Intellia". "Active
Business Park - activeacres". 12 May 2023. "Ecostation". "Ecospace...
- over viral-based
delivery systems.
Companies such as
Editas Medicine,
Intellia Therapeutics,
CRISPR Therapeutics, Casebia, Cellectis,
Precision Biosciences...
-
Healthcare products Regulatory Agency as of
April 2023[update].
Editas Medicine Intellia Therapeutics "CRISPR
Therapeutics AG 2023
Annual Report". U.S. Securities...
